PRDX2 and acute myeloid leukemia: Histone H3 acetylation decreased and methylation increased on the Prdx2 promoter, leading to lower Prdx2 expression and the accumulation of ROS, which further promoted the malignant proliferation of AML cells and poor prognosis in AML patients.